HCV-Flavi 2023
Atlanta, Georgia, USA / 1-4 October 2023
We are happy to announce that the 29th International Symposium on Hepatitis C Virus, Flaviviruses, and Related Viruses will take place in Atlanta from 1 to 4 October, 2023. After the most extraordinary year we can finally say we would love to meet you live in Atlanta next year!
The International Symposium on Hepatitis C Virus, Flaviviridae and Related Viruses is organized on an annual basis and rotates between Europe, North America and Asia/Australia. The symposium's history goes back to 1994 and played a crucial role in the characterization of the hepatitis C virus (HCV) and the discovery of the currently available effective medication for the treatment of chronic hepatitis C.
Program co-chair on behalf of the Organizing Committees,
Arash Grakoui, PhD
Emory University, USA
HCV-Flavi 2023 Organizing Committee
Arash Grakoui, PhD
Conference Chair
Emory University
Rafi Ahmed, PhD
Co-Chair
Emory University
Raymond Schinazi, PhD
Co-Chair
Emory University
hcv flavi 2023: local Scientific Committee
Justin Bailey - Johns Hopkins University, USA
Margo Brinton - Georgia State University, USA
Andrea Cox - Johns Hopkins University, USA
Mike Diamond - Washington University, USA
Hakim Mohamed - Emory University, USA
Alex Ploss - Princeton University, USA
Mehul Suthar - Emory University, USA
HCV-Flavi 2023: International Organizing Committee
Heidi Drummer (chair) - Burnet Institute, Australia
Mark Harris (chair) - University of Leeds, UK
Brett Lindenbach (past chair) - Yale University School of Medicine, USA
Andrea Cox - Johns Hopkins School of Medicine, USA
Arash Grakoui - Emory University, USA
Barbara Rehermann - National Institutes of Health, USA
Daniel Lamarre - Case Western Reserve University, USA
Eui-Cheol Shin - Korea Advanced Institute of Technology, Seoul, Korea
Georg Lauer - Massachusetts General Hospital, Harvard Medical School, USA
Jane McKeating - University of Oxford, United Kingdom
Jordan Feld - University of Toronto, Canada
Lorne Tyrrell - University of Alberta, Canada
Naglaa Shoukry - University de Montréal, Canada
Philip Meuleman - Ghent University, Belgium
Robert Thimme - University of Freiburg, Germany
Nigel Stevenson - Trinity College, Dublin, Ireland
Takaji Wakita - National Institute of Infectious Diseases, Japan
HCV-Flavi 2023: INTERNATIONAL ADVISORY COMMITTEE
Sergio Abrignani - Instituto Nazionale Genetica Molecolare, Italy
Ralf Bartenschlager - Heidelberg University, Germany
Raymond Chung - Massachusetts General Hospital, Harvard Medical School, USA
Michael Houghton - University of Alberta, Canada
Daniel Lamarre - Case Western Reserve University, USA
Stanley Lemon - University of North Carolina, USA
Jake Liang - National Institutes of Health, USA
Yoshii Matsuura - Osaka University, Japan
Tatsuo Miyamura - National Institute of Health and Nutrition, Tokyo, Japan
Jean-Michel Pawlotsky - Henri Mondor University Hospital, France
Charles Rice - Rockefeller University, USA
Lorne Tyrrell - University of Alberta, Canada
Takaji Wakita - National Institute of Infectious Diseases, Japan
Chris Walker - Nationwide Children’s Hospital, USA
